Publications
2010
Shaw SY Blanchard JF , Bernstein CN . Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010 Dec;105(12):2687-92. Epub 2010 Oct 12.
Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D’Haens G, Dotan I, Goh KL, Hibi T, Kozarek RA, Quigley EM, Reinisch W, Sands BE, Sollano JD, Steinhart AH, Steinwurz F, Vatn MH, Yamamoto-Furusho JK. IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010–Inflammatory Bowel Disease Task Force meeting.Inflamm Bowel Dis. 2011 Feb;17(2):639-44.
J . S. Barrett, R. B. Gearry, J. G. Muir, P. M. Irving, R. Rose, O. Rosella, M. L. Haines, S. J . Shepherd & P. R. Gibson.Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010; 31, 874–882.
Lodolce JP, Kolodziej LK, Rhee L, Kariuki SN, Franek BS, McGreal NM, Logsdon MF, Bartulis SJ, Perera MA, Ellis NA, Adams EJ, Hanauer SB, Jolly M, Niewold TB, and Boone DL (2010). African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. Journal of Immunology. 2010 Jun 15;184(12):7001-9
Peyrin-Biroulet L, Cieza A, Sandborn WJ, Kostanjsek N, Kamm MA, Hibi T, Lémann M, Stucki G, Colombel JF.Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis. 2010 Jan;16(1):15-22.
Oral Presentations
Pekow, J., Joseph, L.J., Venu, N., Huang, Y., Gometz, E., Dougherty, U., Liu, Q., Nathanson, J., Cohen, G., Levy, S.E., Hart, J., Yan, B., Noffsinger, A.E., Hanauer, S.B., Hurst, R.D., Fichera, A., Bissonnette, M. Ulcerative Colitis Gene Signature Distinguishes Patients Harboring Remote Dysplasia.Gastroenterology 138: S-46, 2010 (Oral presentation)
2009
Goel A, Mittal A, Evstatiev R, Nemeth M, Kruis W, Stoltes M, Boland R & Gasche C. In vivo effects of mesalazine or E.coli Nissle 1917 on microsatellite instability in ulcerative colitis.Aliment Pharmacol Ther 2009; 30, 634–642
Geert R. D’Haens, MD,* Richard Fedorak, MD, Marc Lemann, MD, Brian G. Feagan, MD, Michael A. Kamm, MD, Jacques Cosnes, MD, Paul J. Rutgeerts, MD, Philippe Marteau, MD, Simon Travis, MD, Jurgen Scholmerich, MD, Steven Hanauer, MD, William J. Sandborn, MD and the IOIBD Membership
Endpoints for Clinical Trials Evaluating Disease Modification and Structural Damage in Adults with Crohn’s Disease 2009
Inflamm Bowel Dis 2009;000:000–000 2009 Endpoints.pdf
Juyal G, Midha V, Amre D, Sood A, Seidman E, Thelma BK.Associations between common variants in the MDR 1 (ABCB 1) gene and ulcerative colitis among North Indians.Pharmacogenet Genomics 2009 Jan;19(1):77-85.
2008
Geboes K, Colombel JF, Greenstein A, Jewell D, Sandborn W, Vatn M, Warren B, Riddell RH. Indeterminate colitis : A review of the concept – What’s in a name? Inflamm Bowel Dis 2008; 14: 860-7
Karel Geboes, MD, Jean-Frederic Colombel, MD, Adrian Greenstein, MD, Derek P. Jewell, MD, William J. Sandborn, MD, Morten H. Vatn, MD, Bryan Warren, MD, Robert H. Riddell, MD,
and The Pathology Task Force of the International Organization of Inflammatory Bowel Diseases (IOIBD; K.G., D.P.J, B.W., R.H.R.)
Indeterminate Colitis: A Review of the Concept — What’s in a Name?
Inflamm Bowel Dis 2008;14:850 – 857 Indeterminate.pdf
Studies as a result of IOIBD Grants
Hafner, S., A. Timmer, H. Herfarth, G. Rogler, J. Schölmerich, A. Schäffler, B. Ehrenstein, W. Jilg, C. Ott, U. Strauch, F. Obermeier:
The role of domestic hygiene in inflammatory bowel disease: Hepatitis A and worm infestations.
Eur. J. Gastroenterol. Hepatol.20, 561-566 (2008)
Ott, C., F. Obermeier, S. Thieler, D. Kemptner, A. Bauer, U. Strauch, J. Schölmerich, G. Rogler, A. Timmer:
The incidence of inflammatory bowel disease in a rural region of southern Germany – a prospective population based study.
Eur. J. Gastroenterol. Hepatol. 20, 917-923 (2008)
2007
Croagh C, Shepherd SJ, Berryman M, Muir JG, Gibson PR. A pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis 2007;13:1522-8.
Geert d’Haens, William J. Sandborn, Brian G. Feagan, Karel Geboes, Stephen B. Hanauer, E. Jan Irvine, Marc Lémann, Philippe Marteau, Paul Rutgeerts, Jurgen Schölmerich, and Lloyd R. Sutherland
A Review of Activity Indices and Efficacy End Points for Clinical Trials of
Medical Therapy in Adults With Ulcerative Colitis
Gastroenterology 2007;132:763–786
2007 A review of activity indices .pdf
Catherine Croagh, MB, BS, Susan J. Shepherd, BApplSci, Melissa Berryman, BApplSci, Jane G. Muir, PhD, and
Peter R. Gibson, MD
Pilot Study on the Effect of Reducing Dietary FODMAP
Intake on Bowel Function in Patients without a Colon
Inflamm Bowel Dis 2007;13:1522–1528
Pouch.pdf
Halfvarson J, Jess T, Bodin L, Järnerot G, Orholm M, Munkholm P, Binder V, Tysk C. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflammatory Bowel Disease 2007;13:1536-1544.
D’Haens, G., W.J. Sandborn, B.G. Feagan, K. Geboes, S.B. Hanauer, E.J. Irvine, M. Lémann, P. Marteau, P. Rutgeerts, J. Schölmerich, L.R. Sutherland:
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with ulcerative colitis.
Gastroenterology 132, 763-786 (2007)
Juyal G, Amre D, Midha V, Sood A, Seidman E, Thelma BK.Evidence of allelic heterogeneity for associations between NOD2/CARD15 gene and ulcerative colitis among North Indians. Aliment Pharmacol Ther. 2007;26(10):1325-32
2006
Halfvarson J, Jess T, Magnuson A, Montgomery S, Orholm M, Tysk C, Binder V, Järnerot G.. Environmental factors in inflammatory bowel disease; a co-twin control study of a Swedish-Danish twin population.Inflammatory Bowel Disease 2006;12: 925-33.
2005
Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J; Is perianal Crohn’s disease associated with intestinal fistulization?
Task Force on Clinical Phenotyping of the IOIBD.
Am J Gastroenterol. 2005 Jul;100(7):1547-9.
Studies as a result of IOIBD Grants
Zankel, E., G. Rogler, T. Andus, C.M. Reng, J. Schölmerich, A. Timmer:
Crohn’s disease patient selection in a tertiary referral center – comparison with patients from a population based cohort.
Eur. J. Gastroenterol. Hepatol. 17, 395-401 (2005)
2004
Perl DP, Fogarty U, Harpaz N, Sachar DB. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn’s disease. Inflamm Bowel Dis 2004;10:881-3. 2004 IOIBD.pdf
2002
William J. Sandborn, Brian G. Feagan, Stephen B. Hanauer, Herbert Lochs, Robert Lofberg, Robert Modigliani, Daniel H. Present, Paul Rutgeerts, Jurgen Scholmerich, Eduard F. Stange, and Lloyd R. Sutherland
A Review of Activity Indices and Efficacy Endpoints for Clinical
Trials of Medical Therapy in Adults With Crohn’s Disease
Gastroenterology 2002;122:512–530
2002 Endpoints.pdf
Sandborn, W.J., B.G. Feagan, S.B. Hanauer, H. Lochs, R. Löfberg, R. Modigliani, D.H. Present, P. Rutgeerts, J. Schölmerich, E.F. Stange, L.R. Sutherland:
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease.
Gastroenterology 122, 512-530 (2002)
2001-2001
Geboes K, Riddell R, Öst Ä, Jensfelt B, Persson T, Löfberg R.A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000; 47: 404-9
Older Publications
Sutherland, L., S. Hanauer, J. Schölmerich:
Standards for Trials of Therapy in Inflammatory Bowel Disease.
Infl. Bowel Dis. 3, 277-283 (1997)
Goebell, H., M. Campieri, T. Gilat, S. Hanauer, B. Korelitz, K. Lauritsen, M. Malchow, F. Martin, M. Miglioli, R. Modigliani, D. Present, J. Schölmerich, L. Sutherland:
Drug trials in Inflammatory Bowel Diseases 1993-1995. A Survey Conducted by the IOIBD.
Inflamm. Bowel Dis. 2, 265-267 (1996)
Campieri, M., H. Goebell, S. Hanauer, B. Korelitz, K. Lauritsen, H. Malchow, F. Martin, M. Miglioli, R. Modigliani, D. Present, J. Schölmerich, L.R. Sutherland:
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials.
Infl. Bowel Dis. 1, 295-298 (1995)
Sachar DB, Luppescu NE, Bodian C, Shlien RD, Fabry TL, Gumaste VV. Erythrocyte sedimentation as a measure of Crohn’s disease activity: opposite trends in ileitis versus colitis. J Clin Gastroenterol 1990; 12:643-6.
Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH, Jr Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 1988;
29:588-92.1988 ioibd gut.pdf
